Skip to main content
An official website of the United States government

2020 Technology Showcase

2023 Technology Showcase graphic Design

September 9, 2020 | 11:45 AM – 5:30 PM


Add to Outlook Calendar

Thank you for attending the 2020 Technology Showcase on September 9th. The 4th annual event highlighted technologies being developed at the NCI and the Frederick National Laboratory (FNL) to encourage technology licensing and collaborations, startup company formation and the translation of NCI discoveries into solutions to benefit patients. If you are interested in learning more about the featured technologies and would like for someone to follow-up with you, please contact us at


  • Free, half-day virtual event
  • Hear from NCI and FNL inventors about technologies primed for technology commercialization and/or collaboration; great opportunity for companies of all sizes including startups and biotech stakeholders
  • Panel sessions focused on technology commercialization
  • Virtual poster session highlighting NCI technologies available for collaborative development and/or licensing presented by the NCI Technology Transfer Ambassadors Program

Detailed Event Schedule

Event Agenda
Time Topic
11:45 a.m.

WebEx event opens

12:00 - 12:30 p.m.

Welcome & Keynote Presenters

12:30 - 1:25 p.m.

Technology Session 1

  1. Stephan Stern, Ph.D., DABT, Laboratory Co-Director, Director of Research and Development, Nanotechnology Characterization Laboratory - "Polymeric Delivery Platform for Therapeutics" E-097-2017
  2. Udo Rudloff, M.D., Ph.D., Investigator, NCI CCR Pediatric Oncology Branch - "Use and Preparation of CD206 Small Molecule Modulators as Therapeutics for CD206-Expressing Cancers" (E-105-2019)
  3. Genoveffa Franchini, M.D., Senior Investigator, NCI CCR, Vaccine Branch - "Preventing HIV Using a Novel Recombinant gp120 Vaccine Modified with a V1-region Deletion" (E-160-2018)
  4. Presented by: Herui Wang, Ph.D., NCI CCR, Neuro-Oncology Branch
    Inventor: Zhengping Zhuang, M.D., Ph.D., Senior Investigator, NCI CCR, Neuro-Oncology Branch - "Use of the TP5 Peptide for the Treatment of Cancer" (E-007-2019)
  5. Javed Khan, M.D., Deputy Chief, NCI CCR, Genetics Branch - "Fibroblast Growth Factor Receptor 4 (FGFR4) Monoclonal Antibodies and Methods of Their Use" (E-264-2015)

1:30 - 2:25 p.m.

Panel Sessions 1

Panels offered concurrently. Attendee selects one.

Panel 1: How to Attract Investors and Funding for Your Company

To attend this session, attendees stay connected to primary WebEx event.

Moderator: Elizabeth Cho-Fertikh, Ph.D., Co-Founder, MEDA Angels, Founder, ECF Biosolutions

Panel 2: Partnering with the NCI and FNL to Advance Innovation to Benefit your Pipeline and Your Bottom-line

To attend this session, attendees stay connected to primary WebEx Event.

Moderator: Vladimir Popov, Ph.D., Director, FNL Partnership Development Office

  • Kathleen Carroll, Ph.D., Associate Director, NCI TTC
  • Serguei Kozlov, Ph.D., M.B.A., Team Leader, NCI CCR, Center for Advanced Preclinical Research: Preclinical Technology and Optimization
  • Maurice T. Hampton, M.S., M.B.A., Executive Chairman and CEO, Telesis Therapeutics, LLC
2:30 - 3:25 p.m.

Technology Transfer Ambassadors Program (TTAP) Virtual Poster Sessions

Posters prepared in partnership with NCI's TTAP will highlight technologies available for licensing and/or commercialization. The following Poster Sessions will be offered concurrently. Attendee selects one.

Poster Group 1

Moderator: Laura Prestia, Ph.D., TTC, Communications and Strategic Initiatives Manager, TTAP Program Lead

  • Presented by: Weiwei Dai, Ph.D., *Johns Hopkins University Student
    Inventor: Stuart Le Grice, Ph.D., NCI, CCR, Basic Research Laboratory "(lncRNA) as Anticancer Agents" (E-060-2018)
  • Presented by: Eric Ho, Ph.D., Transition to Industry (T2I) fellow and co-inventor
    Inventor: David FitzGerald, Ph.D., NCI, CCR, Laboratory of Molecular Biology "EGFRvIII Antibodies for the Treatment of Human Cancer" (E-103-2019)

Poster Group 2

Moderator: Abritee Dhal, Ph.D., TTC Technology Transfer Manager, TTAP Team Lead

  • Presented by: Albert Burgess-Hull, Ph.D., TTAP Ambassador
    Inventor: Melvin DePamphilis, Ph.D., Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH Distinguished Investigator, "Combined PIKFYVE and p38 MAP Kinase Inhibition for Treating Cancer" (E-138-2019)
  • Presented by: Berna Uygur, Ph.D., TTC Fellow
    Inventor: Xin Wei Wang, Ph.D., NCI, CCR, Laboratory of Human Carcinogenesis, "A Viral Exposure Signature to Define and Detect Early Onset Hepatocellular Carcinoma" (E-174-2019)
  • Presented by: Diptadip Dattaroy, Ph.D., TTAP Ambassador/TTC Fellow
    Inventor: Stephen Hewitt, M.D., Ph.D., NCI, CCR, Laboratory of Pathology, "Ratio Based Biomarkers for the Prediction of Cancer Survival" (E-025-2009)
  • Presented by: Fei Zhao, Ph.D., TTAP Ambassador
    Inventor: Allan Weissman, M.D., NCI, CCR, Laboratory of Protein Dynamics and Signaling, "Peptides that Modulate Endoplasmic Reticulum (ER)-Associated Degradation by Sequestering" (E-122-2018)
  • Presented by: Hiba Alsaffar, Ph.D., TTC Fellow
    Inventor: Stanislav Tamarev, Ph.D., Ntional Eye Institute, Retinal Ganglion Cell Biology, "Bone Marrow Mesenchymal Satem Cell (BMSC)-Derived Exosomes for the Treatment of Glaucoma" (E-044-2018)

*Select posters were developed through the TTAP partnership with the Johns Hopkins University

If you are interested in learning more about these technologies and would like for someone to follow-up with you, please contact us at

3:30 - 4:20 p.m.

Technology Session 2

Panels offered concurrently. Attendee selects one.

Panel 3: Government and Non-Profit Funding and Resources for Startups

To attend this session, attendees stay connected to primary WebEx event.

Moderator: Heather Gramm, CEcD, Senior Director, Strategic Industries and Entrepreneurship, Maryland Department of Commerce

  • Christie Canaria, Ph.D., Program Director, NCI SBIR
  • Javeed Froozan, VP Research and Business Development and Strategic Alliances, Leukemia and Lymphoma Society
  • Ulyana V. Desiderio, Ph.D., Director, BioHealth and Life Sciences at Maryland Department of Commerce
  • John Bittman, PSM Interagency Policy Specialist, Technology Partnerships Office, National Institute of Standards and Technology

Panel 4: Leveraging Incubators and Accelerators to Speed Tech Licensing and Commercialization

To attend this session, attendees should connect to separate WebEx event.

Moderator: Kathie Callahan Brady, CEO, Frederick Innovative Technology Center Inc. (FITCI)

  • Xiaonao Liu, Ph.D., CEO, Nanobiofab
  • Sue E. Carr RPh., President and Founder, CarrTech LLC
  • Jon Rowley, Founder & Chief Product Office, RoosterBio, Inc.

If you are interested in learning more about the featured technologies and would like for someone to follow-up with you, please contact us at